journal
https://read.qxmd.com/read/36226729/update-of-pathophysiology-and-treatment-options-of-seborrheic-keratosis
#21
REVIEW
Surajit Gorai, Shahzaib Ahmad, Syeda Sadia Masood Raza, Hadin Darain Khan, Muhammad Asad Raza, Farshid Etaee, Clay J Cockerell, Zoe Apalla, Mohamad Goldust
Seborrheic keratosis (SK) is a common, benign tumor that can occur on everybody site and can be conservatively managed. Cosmetic concerns, especially when a lesion involves the facial area, are the most common reason for excision. SK shows male gender preponderance and increasing age is an independent association with the condition. Even though more prevalent in the elderly, it has also been reported in younger age groups like adolescents and young adults. Precise pathogenesis is still obscure, but ultra-violet exposure represents a predisposing factor to SK by altering the biochemical concentration and expression of factors like Glutamine deaminases, endothelin, and stem cell factor...
December 2022: Dermatologic Therapy
https://read.qxmd.com/read/36226669/tapinarof-for-the-treatment-of-psoriasis
#22
REVIEW
Sofia Nogueira, Maria Alexandra Rodrigues, Ron Vender, Tiago Torres
Although topical drugs are the mainstay of treatment for patients with mild-to-moderate psoriasis, the developments observed in this field in the last two decades have been limited. The most commonly used drugs are still vitamin D analogues and corticosteroids, both with several limitations. The aryl hydrocarbon receptor (AhR) plays a role in the pathogenesis of psoriasis, and tapinarof, a novel, first-in-class, small molecule topical therapeutic AhR-modulating agent has been recently approved by the FDA for the topical treatment of plaque psoriasis in adults...
December 2022: Dermatologic Therapy
https://read.qxmd.com/read/36222320/comparison-between-chronic-spontaneous-urticaria-and-chronic-induced-urticaria-on-the-efficacy-of-omalizumab-treatment-a-systematic-review-and-meta-analysis
#23
REVIEW
Zhu-Han He, Shuo-Cheng Qiu, Zhi-Wei Huang, Guo-Qiang Zhang, Qing-Qing An, Feng Qu, Na Wang
This meta-analysis aimed to assess the efficacy of omalizumab in the treatment of refractory-to-antihistamines chronic induced urticaria (CIndU) in comparison with that of refractory-to-antihistamines chronic spontaneous urticaria (CSU). We retrieved interventional studies and observational studies on omalizumab efficacy to CIndU patients and efficacy comparison between CSU and CIndU both refractory to H1-antihistamines in electronic databases (accessed till May 2022). The odd ratio (OR) and 95% confidence interval (CI) was calculated with a random-effect model in this meta-analysis...
December 2022: Dermatologic Therapy
https://read.qxmd.com/read/36219538/dupilumab-advances-in-the-off-label-usage-of-il4-il13-antagonist-in-dermatoses
#24
REVIEW
Fengming Jia, Qing Zhao, Peidian Shi, Hong Liu, Furen Zhang
Type 2 immune response refers to a complicated series of immune responses characterized by Th2 polarization and Th2 cytokines secretion. The IgE secretion, airway hypersensitivity, and effector cell recruitment (eosinophils, mast cells, basophils) in skin lesion and peripheral blood stream could be upregulated during the activation of type 2 immune response. Th1/Th2 ratio, also referred as Th1/Th2 balance, represent the T lymphocytes immune pattern to a certain degree: Th1-dominated responses are often involved in intracellular infections (e...
December 2022: Dermatologic Therapy
https://read.qxmd.com/read/36219536/rapid-response-of-recalcitrant-linear-iga-bullous-dermatosis-to-omalizumab-a-case-report-and-literature-review
#25
REVIEW
Xin Tong, Long Geng, Xing-Hua Gao, Hong-Hui Xu
No abstract text is available yet for this article.
December 2022: Dermatologic Therapy
https://read.qxmd.com/read/36219526/atypical-presentation-of-sweet-syndrome-with-nodular-erythema-and-oral-ulcerations-provoked-by-ad26-cov2-s-sars-cov-2-vaccination-and-review-of-literature
#26
REVIEW
Agata Bechtold, Agnieszka Owczarczyk-Saczonek
The aim of this article is to present the case of acute febrile neutrophilic dermatosis (Sweet syndrome-SS) after Ad26.COV2.S vaccination against SARS-CoV-2. To the best of our knowledge, this is the second case of SS provoked by this specific vaccine. What is more, the mildly symptomatic beginning of the disease, later followed by typical SS manifestation with a variety of symptoms including nodular erythema of the feet and oral ulcerations, made it very challenging to establish the diagnosis. The article focuses on the current literature on the acute febrile neutrophilic dermatosis, along with the coexistence with other neutrophilic dermatoses and anti-SARS-CoV-2 vaccinations as provoking factors...
December 2022: Dermatologic Therapy
https://read.qxmd.com/read/36219518/which-is-more-effective-in-atrophic-acne-scars-treatment-microneedling-alone-or-platelet-rich-plasma-alone-or-combined-both-therapeutic-modalities
#27
RANDOMIZED CONTROLLED TRIAL
Sahar A Ismail, Nanis A H Khella, Doaa A E Abou-Taleb
Acne scarring usually causes cosmetic and psychological problems. Our aim of the study was to compare the efficacy of microneedling alone, intradermal injection of platelet rich plasma (PRP) alone and combined microneedling with PRP in the treatment of atrophic post-acne scars. Thirty adult patients with facial post-acne scars were randomly recruited and divided into two groups: A and B. Group A: included 15 patients; the left sides of their faces were treated with microneedling by dermapen followed by PRP while on the right side of the faces microneedling alone was performed...
December 2022: Dermatologic Therapy
https://read.qxmd.com/read/36214268/topical-cyclosporine-hydrogel-preparation-a-new-therapeutic-option-in-the-treatment-of-nail-psoriasis
#28
JOURNAL ARTICLE
Giuseppe Gallo, Luca Mastorino, Diego Barilà, Francesco Cattel, Michele Panzone, Pietro Quaglino, Simone Ribero, Paolo Dapavo
Nail psoriasis is a chronic nail disorder that commonly affects psoriatic patients causing severe distress despite the limited body surface area. Treatments for nail psoriasis are limited, as nails are often difficult to treat with topical therapies, and among different systemic agents responses are unpredictable. We carried out a prospective study in order to analyze the effectiveness and tolerability of topical cyclosporine hydrogel ointment in nail psoriasis. Three patients, for a total of 44 nails, were treated with topical cyclosporine hydrogel ointment...
December 2022: Dermatologic Therapy
https://read.qxmd.com/read/36208443/off-label-uses-of-ustekinumab
#29
REVIEW
Lihua Ye, Zhenfei Wu, Changrong Li, Xiaoxia Zhao, Mengjie Wan, Li Wang
Ustekinumab (brand name Stelara®) is a human interleukin-12 and -23 antagonist and has been indicated for the treatments of moderate to severe plaque psoriasis, psoriatic arthritis, Crohn's disease and ulcerative colitis. This review aims to synthesize and interpret the literature evaluating the off-label uses of ustekinumab. We performed searches in PubMed and ClinicalTrials.gov for clinical trials, observational studies, case series, and case reports evaluating label uses of ustekinumab. Studies evaluated the efficacy of ustekinumab for the following conditions: other types of psoriasis (expect plaque psoriasis and psoriatic arthritis), pityriasis rubra pilaris, hidradenitis suppurativa, atopic dermatitis, pyoderma gangrenosum, et al...
December 2022: Dermatologic Therapy
https://read.qxmd.com/read/36205394/real-world-evidence-of-biological-agents-in-dermatology-a-review-of-its-applications-advantages-and-limitations
#30
REVIEW
Jiaqing Shen, Yi Liu
Randomized controlled trials (RCTs) are regarded as the gold standard of evidence-based medicine. However, the disadvantages of RCTs have been well-documented for a lengthy period of time. Due to the carefully controlled conditions, a small group of patients is studied, resulting in a lack of external validity and generalizability. To address this issue, real-world evidence (RWE) has grown in importance as a complement to randomized controlled trials (RCTs). We introduce and describe the databases used by RWE in this post...
December 2022: Dermatologic Therapy
https://read.qxmd.com/read/36200594/children-atopic-dermatitis-diagnosis-mimics-overlaps-and-therapeutic-implication
#31
REVIEW
Maddalena Napolitano, Gabriella Fabbrocini, Fabrizio Martora, Lucia Genco, Matteo Noto, Cataldo Patruno
Atopic dermatitis (AD) is a chronic inflammatory, itching skin with a significant psychosocial impact on patients and relatives. In adults and adolescents besides flexural eczema, head and neck eczema, and hand eczema, which are the most frequent clinical phenotypes (84.9% and 84.2%, respectively), there are also other possible presentation such as, portrait-like dermatitis (20.1%), diffuse eczema (6.5%), eczema nummulare-like (5.8%), prurigo nodularis-like (2.1%) and erythrodermia (0.7%). Diagnosis can be easy due to the typically distributed eczematous lesions, albeit with age-related differences, However, it is also extremely heterogeneous in severity, course, and sometimes particular clinical features...
December 2022: Dermatologic Therapy
https://read.qxmd.com/read/36175129/paradoxical-psoriasiform-reactions-during-treatment-with-adalimumab-for-hidradenitis-suppurativa-real-life-experience-and-therapeutic-response-to-other-biological-drugs
#32
JOURNAL ARTICLE
Lorenza Burzi, Federica Repetto, Simone Ribero, Luca Mastorino, Pietro Quaglino, Paolo Dapavo
Adalimumab is the only biological drug approved to date for the treatment of moderate and/or severe hidradenitis suppurativa. Adverse events reported during therapy include paradoxical psoriasiform reactions. No guidelines are currently available for the management of this clinical condition. The aim of this paper is to describe the incidence and clinical features of paradoxical psoriasiform eruptions occurring during treatment with adalimumab in patients with hidradenitis suppurativa and to report real-life experience in management and the possible role of other biologic agents for the treatment of both conditions...
December 2022: Dermatologic Therapy
https://read.qxmd.com/read/36153705/pigmented-purpuric-dermatosis-persistent-over-20%C3%A2-years-treated-with-an-ozone-nanobubble-water-oral-rinse-a-case-study
#33
JOURNAL ARTICLE
Yasuhiro Horiuchi
Pigmented purpuric dermatosis is a rare, unique purpuric skin disorder, most commonly located on the lower extremities and characterized by petechiae with tiny red rashes and brown pigmented patches. The precise etiology and a reliable treatment have not been established. This case report presents a 72-year-old female with repeating purpuric, tiny rashes and persistent extensive brown pigmented patches with pigmented purpuric dermatosis on both lower extremities for the past 20 years. Ozone nanobubble (ONB) water is a new sterilizing agent containing dissolved nanosized ozone gas bubbles in water...
December 2022: Dermatologic Therapy
https://read.qxmd.com/read/36366826/a-case-of-erythema-nodosum-concomitant-with-ulcerative-colitis-relieved-by-tofacitinib
#34
LETTER
Kanae Nakamura, Emi Sato, Shinichi Imafuku
No abstract text is available yet for this article.
November 10, 2022: Dermatologic Therapy
https://read.qxmd.com/read/36354266/a-case-report-of-vitiligo-following-toripalimab-therapy-for-a-patient-with-metastatic-melanoma
#35
LETTER
Yihao Li, Min Zhang, Hongbin Zhou, Kelei Zhao, Xiaohan Yuan, Yanting Liu, Ping Lu
No abstract text is available yet for this article.
November 10, 2022: Dermatologic Therapy
https://read.qxmd.com/read/36346021/efficacy-and-safety-of-date-palm-leaf-based-ointment-for-treatment-of-cutaneous-warts-a-pilot-clinical-trial
#36
JOURNAL ARTICLE
Azin Ayatollahi, Nima Aramipour, Arash Sadri, Alireza Firooz, Reza M Robati, Mahsa Fattahi, Masoud Ayazi, Mohammad Saber
INTRODUCTION: Despite the considerably high prevalence of cutaneous warts, no optimally effective and safe treatment is available. Leaves of date palm (Phoenix dactylifera L.; Arecaceae) have long been used in Iran's folk medicine as a remedy for warts. METHODS: To assess the state-of-the-art evidence on using P. dactylifera L. for warts, we conducted a systematic review using CINAHL (using EBSCO), Embase, Medline (using PubMed), ProQuest, Scopus, and Web of Science...
November 8, 2022: Dermatologic Therapy
https://read.qxmd.com/read/36183094/exosomes-as-novel-player-in-dermatologic-field
#37
REVIEW
Su Jung Park, Sun Hye Shin, Ka Ram Kim, Joon Seok, Kui Young Park
Exosomes are nano-sized extracellular vesicles released by the majority of the cell types. Exosomes play a major role in intercellular communication via transferring cargoes between cells and altering specific functions of the target cells. The interest in the biological activities of exosomes has been increasing and their therapeutic role has already been demonstrated in various diseases. Recently, there is growing evidence that stem cell-derived exosomes (including mesenchymal stem cell, umbilical cord-derived mesenchymal cell, adipose-derived stem cell, and pluripotent stem cell) can also be used in a variety of skin conditions due to their regenerative and anti-inflammatory capacity...
November 2022: Dermatologic Therapy
https://read.qxmd.com/read/36181400/clinical-and-laboratory-parameters-associated-with-treatment-response-to-third-line-therapies-in-chronic-refractory-urticaria-a-real-world-study-from-northern-india
#38
JOURNAL ARTICLE
Hitaishi Mehta, Anuradha Bishnoi, Davinder Parsad, Muthu Sendhil Kumaran
Current guidelines recommend omalizumab and cyclosporine for management of chronic spontaneous urticaria (CSU) refractory to anti-histamines. Identification of clinico-epidemiological characteristics predictive of treatment response with both modalities which will aid therapy selection. Clinical records of CSU patients receiving omalizumab and cyclosporine from May 1, 2016 to December 31, 2020 were reviewed retrospectively. Patients with a minimum follow-up duration of 4 months were included in the analysis...
November 2022: Dermatologic Therapy
https://read.qxmd.com/read/36177802/off-label-uses-of-hyaluronic-acid-fillers-a-review
#39
REVIEW
Poonam Tapsale, Belma Türsen, Ümit Türsen
Food and Drug Administration approved indications of hyaluronic acid fillers include some facial wrinkles or skin folds like naso-labial folds, perioral wrinkles, volumization of lip, cheek, chin, and dorsal region of the hands, also acne scars and lipoatrophy of human immunodeficiency virus positive patients. This article reviews the off-label indications of hyaluronic acid fillers such as connective tissue disorders (lupus erythematosus, scleroderma, and dermatomyositis), lipoatrophy associated with other diseases, breast volumization, giving volume to buttocks and the feet, implant into bone, tendon, ligament or muscle, injection to glabella, nose, periorbital region, forehead, or neck...
November 2022: Dermatologic Therapy
https://read.qxmd.com/read/36175141/guselkumab-effectiveness-and-survival-in-patients-with-psoriasis-and-psoriatic-arthritis-multicenter-analysis-in-daily-clinical-practice-by-the-spanish-psoriasis-group
#40
MULTICENTER STUDY
Vicenç Rocamora, Laura Crespi, Marta Ferran, Mar Llamas-Velasco, Elena Del Alcázar, José M Carrascosa, Emma Beltran, Ana Urruticoechea-Arana, José Luis López Estebaranz, David Vidal, Josep Riera, Lourdes Rodríguez, Susana Armesto, Josep M Fernández, Gloria Aparicio, Silvia Pérez, Saray Porcar, Encarna Montesinos, Fernando Gallardo
Guselkumab is a monoclonal antibody that selectively blocks the p19 subunit of interleukin 23 and has been approved for the treatment of moderate to severe psoriasis and active psoriatic arthritis in adult patients due to its efficacy in different clinical trials. Therefore, itis important to know the performance of guselkumab in this setting of patients in clinical practice given that a high percentage of them are not represented in these clinical trials. Our objective was to evaluate the effectiveness and tolerability of guselkumab in clinical practice in the first patients with psoriasis and psoriatic arthritis treated since the date of its approval for psoriasis in Spain, in joint dermatology-rheumatology clinics...
November 2022: Dermatologic Therapy
journal
journal
32674
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.